![Frederick Callori](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frederick Callori
Director/Board Member at
LEONABIO, INC.
Net worth: - $ as of 2026-06-29
Profile
Frederick P.
Callori is Chairman & Chief Executive Officer at Neurosterix SA since 2024.
Holds the position of Independent Director at LeonaBio, Inc. starting 2026.
Serves as Director at CereVasc, Inc., Quellis Biosciences LLC, Zucara Therapeutics, Inc., and Polycore Therapeutics, Inc. Managing Director & Venture at Perceptive Advisors (Private Equity) since 2018.
Former Independent Director at Astria Therapeutics, Inc. from 2021 to 2026 and at Landos Biopharma, Inc. from 2021 to 2024.
Partner at Choate, Hall & Stewart LLP from 1998 to 2017.
Executive Vice President & Senior Partner at Xontogeny LLC from 2023 to 2024.
Educated at State University of New York at Binghamton (undergraduate) and Boston University School of Law (graduate).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LEONABIO, INC. -.--% | 2026-06-22 | 0 ( -.--% ) | - $ | 2026-06-29 |
Frederick Callori active positions
| Companies | Position | Start |
|---|---|---|
| LEONABIO, INC. | Director/Board Member | 2026-05-04 |
CereVasc, Inc.
 CereVasc, Inc. Medical SpecialtiesHealth Technology Develops medical devices for neurological diseases | Director/Board Member | - |
Zucara Therapeutics, Inc.
 Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people | Director/Board Member | - |
Quellis Biosciences LLC
 Quellis Biosciences LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that develops antibody therapies | Director/Board Member | - |
Polycore Therapeutics, Inc.
 Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatment for central nervous system diseases | Director/Board Member | - |
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Private Equity Investor | 2017-12-31 |
Former positions of Frederick Callori
| Companies | Position | End |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Director/Board Member | 2026-01-22 |
Xontogeny LLC
 Xontogeny LLC Pharmaceuticals: MajorHealth Technology Operates biotech aggregator company | Corporate Officer/Principal | 2024-11-30 |
| LANDOS BIOPHARMA, INC. | Director/Board Member | 2024-05-22 |
| ░░░░░░░ ░░░░ ░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Frederick Callori
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
36
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Choate, Hall & Stewart LLP
 Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
LeonaBio, Inc.
 LeonaBio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
State University of New York at Binghamton
 State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Law
 Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CereVasc, Inc.
CereVasc, Inc. Medical SpecialtiesHealth Technology Develops medical devices for neurological diseases | Health Technology |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Finance |
Landos Biopharma, Inc.
 Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Xontogeny LLC
Xontogeny LLC Pharmaceuticals: MajorHealth Technology Operates biotech aggregator company | Health Technology |
Quellis Biosciences LLC
Quellis Biosciences LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that develops antibody therapies | Health Technology |
Zucara Therapeutics, Inc.
Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people | Health Technology |
Polycore Therapeutics, Inc.
Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatment for central nervous system diseases | Health Technology |
- Stock Market
- Insiders
- Frederick Callori
Choose MarketScreener 
